RAS inhibitors vs thiazides
End‐stage renal disease · patients with hypertension
RAS inhibitors showed no clear difference in end stage renal failure compared with thiazides (low certainty).
1 finding from 1 review
- First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for… 2018 · Cochrane Headline outcomes onlyRR 1.1 [0.88, 1.37]1 study · 24309 participantsLow